Recombinant Human Epidermal Growth Factor Topical Solution and Gel therapeutically work the same, but in different formulations. Both can be used in the treatment of difficult-to-heal wounds, incision healing disorders and other diseases, and should not be used by people who are allergic to natural and recombinant hEGF and other drugs. Recombinant human epidermal growth factor topical solution and recombinant human epidermal growth factor gel belong to the same kind of efficacy of the drug, both are drugs for external use. However, the preparations of the two drugs are different. Recombinant human epidermal growth factor topical solution is a liquid solution and recombinant human epidermal growth factor gel is a solid gel. Both Recombinant Human Epidermal Growth Factor Topical Solution and Recombinant Human Epidermal Growth Factor Gel can be used in the treatment of difficult-to-heal wounds, disorders such as impaired incision healing, and also in the prevention and reduction of surgical scars. However, these two medications are contraindicated for people who are allergic to natural and recombinant hEGF, glycerin, mannitol and other drug ingredients to prevent over symptoms such as shock, breathing difficulties, itchy skin and so on. No serious adverse reactions have been observed with recombinant human epidermal growth factor topical solution and gel. Note that the drugs are packaged in sterile packaging and should be stored carefully after use to prevent contamination. Recombinant Human Epidermal Growth Factor Topical Solution and Recombinant Human Epidermal Growth Factor Gel have the same therapeutic effect, and patients should consult their doctors before using the drugs to avoid unauthorized use.